{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T23:06:54Z","timestamp":1765667214699,"version":"3.37.3"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2018,7,4]],"date-time":"2018-07-04T00:00:00Z","timestamp":1530662400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Gastroenterol Hepatol"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1038\/s41575-018-0043-4","type":"journal-article","created":{"date-parts":[[2018,7,4]],"date-time":"2018-07-04T09:25:42Z","timestamp":1530696342000},"page":"583-584","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["T cells in coeliac disease: a\u00a0rational target for diagnosis and therapy"],"prefix":"10.1038","volume":"15","author":[{"given":"Melinda Y.","family":"Hardy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7687-9654","authenticated-orcid":false,"given":"Jason A.","family":"Tye-Din","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,7,4]]},"reference":[{"key":"43_CR1","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1038\/nri3407","volume":"13","author":"LM Sollid","year":"2013","unstructured":"Sollid, L. M. & Jabri, B. Triggers and drivers of autoimmunity: lessons from coeliac disease. Nat. Rev. Immunol. 13, 294\u2013302 (2013).","journal-title":"Nat. Rev. Immunol."},{"key":"43_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/scitranslmed.3001012","volume":"2","author":"JA Tye-Din","year":"2010","unstructured":"Tye-Din, J. A. et al. Comprehensive, quantitative mapping of T cell epitopes in gluten in celiac disease. Sci. Transl Med. 2, 1\u201314 (2010).","journal-title":"Sci. Transl Med."},{"key":"43_CR3","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/73200","volume":"6","author":"RP Anderson","year":"2000","unstructured":"Anderson, R. P. et al. In vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T cell epitope. Nat.\u00a0Med. 6, 337\u2013342 (2000).","journal-title":"Nat. Med."},{"key":"43_CR4","doi-asserted-by":"publisher","first-page":"2642","DOI":"10.1172\/JCI98819","volume":"128","author":"LF Risnes","year":"2018","unstructured":"Risnes, L. F. et al. Disease-driving CD4+ T cell clonotypes persist for decades in celiac disease. J. Clin. Invest. 128, 2642\u20132650 (2018).","journal-title":"J. Clin. Invest."},{"key":"43_CR5","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1053\/j.gastro.2015.07.013","volume":"149","author":"MY Hardy","year":"2015","unstructured":"Hardy, M. Y. et al. Consistency in polyclonal T cell responses to gluten between children and adults with celiac disease. Gastroenterology 149, 1541\u20131552.e12 (2015).","journal-title":"Gastroenterology"},{"key":"43_CR6","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1053\/j.gastro.2017.05.016","volume":"153","author":"M Raki","year":"2017","unstructured":"Raki, M. et al. Similar responses of intestinal T cells from untreated children and adults with celiac disease to deamidated gluten epitopes. Gastroenterology 153, 787\u2013798.e4 (2017).","journal-title":"Gastroenterology"},{"key":"43_CR7","doi-asserted-by":"publisher","first-page":"3064","DOI":"10.4049\/jimmunol.1101526","volume":"187","author":"SW Qiao","year":"2011","unstructured":"Qiao, S. W. et al. Posttranslational modification of gluten shapes TCR usage in celiac disease. J. Immunol. 187, 3064\u20133071 (2011).","journal-title":"J. Immunol."},{"key":"43_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-18137-9","volume":"7","author":"DA Yohannes","year":"2017","unstructured":"Yohannes, D. A. et al. Deep sequencing of blood and gut T cell receptor beta-chains reveals gluten-induced immune signatures in celiac disease. Sci. Rep. 7, 17977 (2017).","journal-title":"Sci. Rep."},{"key":"43_CR9","doi-asserted-by":"publisher","first-page":"10020","DOI":"10.3390\/nu7125515","volume":"7","author":"S Picascia","year":"2015","unstructured":"Picascia, S. et al. Gliadin-specific T-cells mobilized in the peripheral blood of coeliac patients by short oral gluten challenge: clinical applications. Nutrients 7, 10020\u201310031 (2015).","journal-title":"Nutrients"},{"key":"43_CR10","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/S2468-1253(17)30110-3","volume":"2","author":"G Goel","year":"2017","unstructured":"Goel, G. et al. Epitope-specific immunotherapy targeting CD4-positive T cells in coeliac disease: two randomised, double-blind, placebo-controlled phase 1 studies. Lancet Gastroenterol. Hepatol. 2, 479\u2013493 (2017).","journal-title":"Lancet Gastroenterol. Hepatol."}],"container-title":["Nature Reviews Gastroenterology & Hepatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41575-018-0043-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41575-018-0043-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41575-018-0043-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:50:32Z","timestamp":1684619432000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41575-018-0043-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,4]]},"references-count":10,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["43"],"URL":"https:\/\/doi.org\/10.1038\/s41575-018-0043-4","relation":{},"ISSN":["1759-5045","1759-5053"],"issn-type":[{"type":"print","value":"1759-5045"},{"type":"electronic","value":"1759-5053"}],"subject":[],"published":{"date-parts":[[2018,7,4]]},"assertion":[{"value":"4 July 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.H. and J.T.-D. are co-inventors of patents pertaining to the use of gluten peptides in therapeutics, diagnostics, and nontoxic gluten. J.T.-D. holds shares in Nexpep and is on the scientific advisory board of ImmusanT.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}